Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired, potentially life-threatening disorder. It causes the red blood cells to break apart, a process called hemolysis. This releases hemoglobin ...

It is estimated that approximately 10-20 people per million worldwide live with PNH. It can develop at any age, though it is often diagnosed in people between 30-40 years old. Significant unmet ...

(RTTNews) - Omeros Corp. (OMER), Friday announced that it has initiated clinical trial site activation for its Phase 3 program evaluating zaltenibart or OMS906 in paroxysmal nocturnal ...

It is estimated that approximately 10-20 people per million worldwide live with PNH. It can develop at any age, though is often diagnosed in people between 30-40 years old. Between 20% and 50% of ...